Eagle Pharmaceuticals Inc (EGRX)
OTHER OTC:EGRX
US Market
Holding EGRX?
Track your performance easily

Eagle Pharmaceuticals (EGRX) Income Statement

208 Followers

Eagle Pharmaceuticals Income Statement

Last quarter (Q2 2023), Eagle Pharmaceuticals's total revenue was $64.65M, a decrease of -12.80% from the same quarter last year. In Q2, Eagle Pharmaceuticals's net income was $5.16M. See Eagle Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 257.55M$ 316.61M$ 171.55M$ 187.80M$ 195.89M$ 213.31M
Cost of Revenue
$ 28.75M$ 94.94M$ 42.18M$ 45.47M$ 47.89M$ -42.37M
Gross Profit
$ 181.50M$ 221.67M$ 129.37M$ 142.34M$ 148.00M$ 170.94M
Operating Expense
$ 74.92M$ 150.19M$ 137.25M$ 121.20M$ 126.19M$ 124.47M
Operating Income
$ 41.01M$ 80.96M$ 2.77M$ 32.95M$ 21.82M$ 46.47M
Net Non Operating Interest Income Expense
$ -5.81M$ -3.77M$ -1.07M$ -2.02M$ -517.00K$ -2.58M
Other Income Expense
$ 6.04M$ 15.75M$ 6.24M$ 8.26M$ -700.00K$ -763.00K
Pretax Income
$ 29.17M$ 61.43M$ -4.55M$ 22.68M$ 22.00M$ 34.04M
Tax Provision
$ 17.22M$ 25.79M$ 4.08M$ 10.69M$ 7.68M$ 2.13M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 11.95M$ 35.64M$ -8.63M$ 11.99M$ 14.31M$ 31.90M
Basic EPS
$ 0.92$ 2.76$ -0.66$ 0.89$ 1.04$ 2.16
Diluted EPS
$ 0.90$ 2.73$ -0.66$ 0.87$ 1.01$ 2.09
Basic Average Shares
$ 52.34M$ 12.93M$ 13.05M$ 13.48M$ 13.75M$ 14.77M
Diluted Average Shares
$ 52.83M$ 13.07M$ 13.05M$ 13.77M$ 14.14M$ 15.28M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 216.55M$ 235.65M$ 168.78M$ 154.85M$ 174.08M$ 82.10M
Net Income From Continuing And Discontinued Operation
$ 11.95M$ 35.64M$ -8.63M$ 11.99M$ 14.31M$ 31.90M
Normalized Income
$ 23.04M$ 48.53M$ -3.59M---
Interest Expense
------
EBIT
$ 35.26M$ 65.48M$ -2.91M$ 25.25M$ 24.68M$ 36.77M
EBITDA
$ 56.78M$ 77.50M$ 847.00K$ 28.79M$ 29.80M$ 40.82M
Currency in USD

Eagle Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis